These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17347804)

  • 21. Feedback for patients reporting adverse drug reactions; satisfaction and expectations.
    Rolfes L; van Hunsel F; van Grootheest K; van Puijenbroek E
    Expert Opin Drug Saf; 2015 May; 14(5):625-32. PubMed ID: 25766456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
    Chopra D; Wardhan N; Rehan HS
    Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
    Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subjective Reasons for Non-Reporting of Adverse Drug Reactions in a Sample of Physicians in Outpatient Care.
    Gahr M; Eller J; Connemann BJ; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2016 Mar; 49(2):57-61. PubMed ID: 26744100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.
    Sanghavi DR; Dhande PP; Pandit VA
    Int J Risk Saf Med; 2013; 25(4):197-204. PubMed ID: 24305558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reporting of adverse drug reactions by hospital doctors and the response to intervention.
    McGettigan P; Golden J; Conroy RM; Arthur N; Feely J
    Br J Clin Pharmacol; 1997 Jul; 44(1):98-100. PubMed ID: 9241104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
    Figueiras A; Herdeiro MT; Polónia J; Gestal-Otero JJ
    JAMA; 2006 Sep; 296(9):1086-93. PubMed ID: 16954488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
    Aziz Z; Siang TC; Badarudin NS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reporting of side-effects--a system in need of improvement. Reporting of a physician questionnaire].
    Ekbom Y; Hedenmalm K; Dalin L; Lönnroth K; Persson I
    Lakartidningen; 2002 Aug; 99(34):3290-5. PubMed ID: 12362847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
    Lee KK; Chan TY; Raymond K; Critchley JA
    Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes to reporting adverse drug reactions in northern Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R; Nordkvist-Olsson T
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):729-32. PubMed ID: 11214784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group.
    Belton KJ
    Eur J Clin Pharmacol; 1997; 52(6):423-7. PubMed ID: 9342576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.